These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14570342)

  • 1. Equal effectiveness of older traditional antibiotics and newer broad-spectrum antibiotics in treating patients with acute exacerbations of chronic bronchitis.
    Peng CC; Aspinall SL; Good CB; Atwood CW; Chang CC
    South Med J; 2003 Oct; 96(10):986-91. PubMed ID: 14570342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
    Dever LL; Shashikumar K; Johanson WG
    Expert Opin Investig Drugs; 2002 Jul; 11(7):911-25. PubMed ID: 12084002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
    Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
    Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.
    Albertson TE; Louie S; Chan AL
    J Am Geriatr Soc; 2010 Mar; 58(3):570-9. PubMed ID: 20398122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of treating lower respiratory tract infections.
    Monte SV; Paolini NM; Slazak EM; Schentag JJ; Paladino JA
    Am J Manag Care; 2008 Apr; 14(4):190-6. PubMed ID: 18402511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of ambulatory acute exacerbations of chronic bronchitis with older versus newer antimicrobials.
    Madaras-Kelly KJ; Magdanz SB; Johnson CK; Jue SG
    Ann Pharmacother; 2002 Jun; 36(6):975-80. PubMed ID: 12022895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
    Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
    Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.
    Wilson R; Jones P; Schaberg T; Arvis P; Duprat-Lomon I; Sagnier PP;
    Thorax; 2006 Apr; 61(4):337-42. PubMed ID: 16449273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics in acute exacerbations of chronic bronchitis.
    Sethi S
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):405-17. PubMed ID: 20377336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
    Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
    Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.
    Anzueto A; Miravitlles M
    Respir Med; 2010 Oct; 104(10):1396-403. PubMed ID: 20580215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review.
    Halpern MT; Higashi MK; Bakst AW; Schmier JK
    J Manag Care Pharm; 2003; 9(4):353-9. PubMed ID: 14613454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S; Decramer M; Laekeman G
    Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
    Destache CJ; Dewan N; O'Donohue WJ; Campbell JC; Angelillo VA
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():107-13. PubMed ID: 10225580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Martinez FJ; Anzueto A
    Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
    Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a COPD severity score.
    Wu EQ; Birnbaum HG; Cifaldi M; Kang Y; Mallet D; Colice G
    Curr Med Res Opin; 2006 Sep; 22(9):1679-87. PubMed ID: 16968571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
    Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
    Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of broad-spectrum antibiotic use for acute sinusitis, chronic bronchitis, and pneumonia in a managed care population.
    Coughlin CM; Nelson M; Merchant S; Gondek K
    Manag Care Interface; 2003 Jun; 16(6):34-40, 55. PubMed ID: 12841074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.